Vaxfab Enterprises Allots 19,50,348 Equity Shares Upon Conversion of Warrants on Preferential Basis

Vaxfab Enterprises Limited, in a Board of Directors meeting held on May 11, 2026, approved the allotment of 19,50,348 equity shares of face value ₹10/- each at a price of ₹21.02/- per share, upon conversion of outstanding equity share warrants into fully paid-up equity shares on a preferential basis. The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Schedule III of the said Regulations. The board meeting commenced at 9.00 A.M. and concluded at 9.20 A.M.

Allotment Details

The equity shares were allotted upon exercise of outstanding equity share warrants, which had originally been issued by way of a preferential allotment. Each warrant carried the right to subscribe to one equity share per warrant at a total exercise price of ₹21.02/-, comprising ₹5.255/- paid at the time of allotment of warrants and ₹15.765/- payable at the time of conversion into equity shares. The allotted equity shares rank pari-passu in all respects with the existing equity shares of the company. The tenure of the warrants did not exceed 18 months from the date of their allotment.

The following table summarises the key parameters of this allotment:

Parameter: Details Type of Securities: Equity Shares upon conversion of Equity Share Warrants Type of Issuance: Preferential Allotment Number of Shares Allotted: 19,50,348 Face Value: ₹10/- per share Allotment Price: ₹21.02/- per share Number of Investors: 6 Post-Allotment Paid-Up Capital: ₹25,46,89,250/- Total Shares Post-Allotment: 2,54,68,925

Impact on Share Capital

Consequent to this allotment, the paid-up equity share capital of Vaxfab Enterprises increased to ₹25,46,89,250/- (Rupees Twenty-five crore forty-six lakh eighty-nine thousand two hundred fifty only), comprising 2,54,68,925 equity shares of face value ₹10/- each.

Investor-Wise Allotment Breakdown

The 19,50,348 equity shares were allotted to six investors upon conversion of their respective warrants. The warrant exercise amount was received at ₹15.765/- per warrant at the time of conversion. The table below provides a detailed investor-wise breakdown:

Investor Name: Warrants Allotted Warrants Held Before Conversion Warrants Applied for Conversion Exercise Amount Received (₹) Equity Shares Allotted Warrants Held After Conversion Sanjay Vinodbhai Chauhan 713606 650175 627973 9899994 627973 22202 Devang Jani 523311 523311 523311 8249998 523311 0 Gopi Darshan Mehta 95147 53917 53917 850001.5 53917 0 Dhara Ronak Bhut 237869 158580 158580 2500014 158580 0 MN Trading 237869 47512 47512 749026.7 47512 0 Ashwinkumar Danabhai Chauhan 237869 73899 69775 1100003 69775 4124

Regulatory Compliance

The allotment was carried out in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023. The requisite disclosures have been submitted to BSE Limited and The Calcutta Stock Exchange Limited. The allotment was approved and signed by Ravindra Ashokbhai Joshi, Managing Director (DIN: 10112296).

Vaxfab enterprises Limited has successfully completed the allotment of 13,28,861 equity shares following the conversion of warrants by investors. The board of directors approved this allotment during their meeting held on April 17, 2026, marking a significant capital expansion for the Ahmedabad-based company.

Allotment Details and Pricing Structure

The equity shares were allotted at a price of Rs. 21.02 per share, with each share carrying a face value of Rs. 10. The allotment was conducted on a preferential basis to three institutional investors who exercised their warrant conversion rights.

Parameter Details Total Shares Allotted 13,28,861 equity shares Face Value per Share Rs. 10 Allotment Price Rs. 21.02 per share Number of Investors 3 Warrant Exercise Price Rs. 15.765 per warrant

Investor-wise Allocation Breakdown

The warrant conversion was executed by three limited liability partnerships, with varying levels of participation in the conversion process.

Investor Name Warrants Applied for Conversion Equity Shares Allotted Exercise Amount (Rs.) Sparkling Tradewing LLP 1,01,460 1,01,460 15,99,516.90 Kushmanda Tradeline LLP 76,117 76,117 11,99,984.50 Lankini Management Consultancy LLP 11,51,284 11,51,284 1,81,49,992.26

Lankini Management Consultancy LLP emerged as the largest participant, converting 11,51,284 warrants while retaining 7,80,147 unconverted warrants. Sparkling Tradewing LLP fully converted all its eligible warrants, while Kushmanda Tradeline LLP retained 3 unconverted warrants.

Impact on Share Capital Structure

The warrant conversion has resulted in a substantial increase in the company's equity base. Following the allotment, Vaxfab Enterprises' paid-up equity share capital expanded to Rs. 22,20,00,270, comprising 2,22,00,027 equity shares of Rs. 10 face value each.

The newly allotted equity shares will rank pari-passu with existing equity shares, providing equal rights and privileges to the new shareholders. This expansion strengthens the company's capital foundation and provides additional financial resources for business operations.

Warrant Conversion Framework

The original warrants were issued with a conversion tenure not exceeding 18 months from the allotment date. The conversion process involved a two-stage payment structure, where investors initially paid Rs. 5.255 per warrant during the original allotment and subsequently paid Rs. 15.765 per warrant at the time of conversion to equity shares.

This successful warrant conversion demonstrates investor confidence in Vaxfab Enterprises' business prospects and provides the company with enhanced financial flexibility for future growth initiatives.

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.

We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.

This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.

The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.

We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.

This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.

By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.

We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.